Ποια είναι η τιμή για Abnova (Taiwan) Corporation (4133)

Η τιμή για Abnova (Taiwan) Corporation (4133) είναι $0.66300973

Ποια είναι η κεφαλαιοποίηση αγοράς για Abnova (Taiwan) Corporation (4133)

Η κεφαλαιοποίηση αγοράς για Abnova (Taiwan) Corporation (4133) είναι $40.15M

Abnova (Taiwan) Corporation (4133) Τιμή και Κεφαλαιοποίηση Αγοράς

Abnova (Taiwan) Corporation specializes in the development and distribution of a comprehensive range of recombinant proteins and antibodies. The company's extensive product portfolio caters to diverse research and diagnostic applications, featuring specialized reagents for SARS-CoV/CoV-2, nucleic acids (both DNA and RNA), and various proteins and peptides. Their offerings further include items like DNAxPab, laboratory beads, dyes, cellular lysates, microscopic slides, antibody pairs and associated kits, as well as antibody and tissue arrays. Additionally, they provide in situ hybridization products, advanced laboratory systems and automation, GMP-grade and analyte-specific reagents, and solutions for in vitro diagnostics. Beyond these product lines, Abnova supplies a broad spectrum of antibody types, such as MaxPab, monoclonal, polyclonal, recombinant, conjugate, secondary/tag, IHC/pathology, and those specifically targeting circulating rare cells. The company also delivers integrated solutions and services, encompassing gene synthesis and cytogenetic analysis, peptide services, protein expression and conjugations, custom antibody generation, and assay development. Abnova (Taiwan) Corporation operates from its headquarters in Taipei, Taiwan.

Η τιμή για 4133	Το περιουσιακό στοιχείο B	Η κεφαλαιοποίηση αγοράς του B	Αποτελέσματα
$87,483.83 $40.15M	NVDA	$5.297T	+13,194,854.54%
$76,912.52 $40.15M	AAPL	$4.657T	+11,600,411.08%
$67,768.17 $40.15M	GOOG	$4.104T	+10,221,194.11%
$58,995.19 $40.15M	MSFT	$3.572T	+8,897,988.68%
$46,446.13 $40.15M	AMZN	$2.812T	+7,005,245.88%

Η τιμή για 4133

Το περιουσιακό στοιχείο B

Η κεφαλαιοποίηση αγοράς του B

Αποτελέσματα

$87,483.83 $40.15M